Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion type Assertion NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_head.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion description "[In addition, this subtype of t-AML is characterized by a unique expression profile (higher expression of genes) involved in cell cycle control (CCNA2, CCNE2, CDC2), checkpoints (BUB1), or growth (MYC), loss of expression of IRF8, and overexpression of FHL2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_provenance.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion evidence source_evidence_literature NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_provenance.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion SIO_000772 19958752 NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_provenance.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion wasDerivedFrom befree-2016 NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_provenance.
- NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_assertion wasGeneratedBy ECO_0000203 NP779271.RAJeUfqwJ_YeTe_ITvJN11YkQ1YncVSC57PSlTxe6PgMU130_provenance.